Answers are grounded in this paper and cite their sources.
A new type of synthetic inhibitor of DNA topoisomerase I and II was examined and several of these derivatives exhibited strong dual activity against these enzymes. This series of compounds showed high cytotoxic activities against cancer cells, but only a limited number of compounds showed any noticeable activity in an in vivo test against murine P388. Non-specific toxicity was observed in the in vivo tests.
No takes yet. Share an insight, caveat, or question.
Katayama et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: